You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study

Article info

Article menu

Download PDFPDF

Neurology
Original research
First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study

Authors

  • Katja Menzler Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany PubMed articlesGoogle scholar articles
  • Peter Michael Mross Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany PubMed articlesGoogle scholar articles
  • Felix Rosenow Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany Center for Personalized Translational Epilepsy Research (CePTER) PubMed articlesGoogle scholar articles
  • Susanne Schubert-Bast Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany Center for Personalized Translational Epilepsy Research (CePTER) Department of Child Neurology, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Laurent Maximilian Willems Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany PubMed articlesGoogle scholar articles
  • Felix Zahnert Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany PubMed articlesGoogle scholar articles
  • Ilka Immisch Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany PubMed articlesGoogle scholar articles
  • Sven Fuest Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany PubMed articlesGoogle scholar articles
  • Felix von Podewils Epilepsy Center Greifswald and Department of Neurology, Ernst-Moritz-Arndt-University, Greifswald, Germany PubMed articlesGoogle scholar articles
  • Rhina Kunz Epilepsy Center Greifswald and Department of Neurology, Ernst-Moritz-Arndt-University, Greifswald, Germany PubMed articlesGoogle scholar articles
  • Martin Hirsch Epilepsy Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany PubMed articlesGoogle scholar articles
  • Tamara Mueller Epilepsy Center Erlangen, Department of Neurology, University of Erlangen, Erlangen, Germany PubMed articlesGoogle scholar articles
  • Justus Marquetand Epilepsy Center Tuebingen, Department of Neurology, University Hospital Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Yaroslav Winter Epilepsy Center Mainz, Department of Neurology, Johannes Gutenberg-University Mainz, Mainz, Germany PubMed articlesGoogle scholar articles
  • Lisa Langenbruch Department of Neurology, University of Münster, Münster, Germany PubMed articlesGoogle scholar articles
  • Michal Cicanic Sächsisches Epilepsiezentrum Radeberg gGmbH, Kleinwachau, Germany PubMed articlesGoogle scholar articles
  • Stefan Beyenburg Hospital Center of Luxembourg, Luxembourg, Luxembourg PubMed articlesGoogle scholar articles
  • Adam Strzelczyk Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany Center for Personalized Translational Epilepsy Research (CePTER) PubMed articlesGoogle scholar articles
  • Susanne Knake Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany Center for Personalized Translational Epilepsy Research (CePTER) PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Katja Menzler; hattemer{at}med.uni-marburg.de
View Full Text

Citation

Menzler K, Mross PM, Rosenow F, et al
First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study
BMJ Open 2019;9:e030746. doi: 10.1136/bmjopen-2019-030746

Publication history

  • Received April 9, 2019
  • Revised September 20, 2019
  • Accepted September 26, 2019
  • First published November 4, 2019.
Online issue publication 
November 04, 2019
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.